Overview

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to assess the safety and efficacy of Bimatoprost/Timolol Fixed Combination in patients with glaucoma or ocular hypertension
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost
Timolol
Criteria
Inclusion Criteria:

- Clinical diagnosis of ocular hypertension or chronic glaucoma in both eyes

- Patient requires IOP-lowering drug in both eyes

Exclusion Criteria:

- Uncontrolled medical condition

- Contraindication to beta-adrenoceptor antagonist therapy